Page last updated: 2024-08-24

irinotecan and Soft Tissue Neoplasms

irinotecan has been researched along with Soft Tissue Neoplasms in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	5 (71.43)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pappo, A; Paulino, AC	1
Attinà, G; Coccia, P; Riccardi, R; Ruggiero, A; Scalzone, M	1
Dharmarajan, KV; Wexler, LH; Wolden, SL	1
Arcamone, G; Bertolini, P; Bisogno, G; Carli, M; Paolucci, P; Prete, A; Provenzi, M; Riccardi, R; Ruggiero, A; Surico, G	1
Chamberlain, MC; Chen, TC; Gupta, V; Hofman, FM; Liebes, LF; Samuelson, CG; Schönthal, AH; Su, YS	1
Ando, M; Hirayama, Y; Kohda, K; Konuma, Y; Nakamura, Y; Obata, M; Seki, R; Wada, Y; Yoshida, M	1
Doihara, H; Takashima, S; Yokoyama, N	1

Trials

2 trial(s) available for irinotecan and Soft Tissue Neoplasms

Article	Year
Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: a report on toxicity and efficacy from a prospective pilot phase II study. Pediatric blood & cancer, 2013, Volume: 60, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemoradiotherapy; Child; Female; Humans; Irinotecan; Male; Pilot Projects; Rhabdomyosarcoma; Soft Tissue Neoplasms	2013
Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma. Cancer, 2006, Feb-01, Volume: 106, Issue:3 Topics: Adolescent; Antineoplastic Agents, Phytogenic; Camptothecin; Child; Child, Preschool; Disease Progression; Drug Administration Schedule; Female; Humans; Infant; Infusions, Intravenous; Irinotecan; Male; Neutropenia; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome	2006

Article

Year

Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: a report on toxicity and efficacy from a prospective pilot phase II study.

Pediatric blood & cancer, 2013, Volume: 60, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemoradiotherapy; Child; Female; Humans; Irinotecan; Male; Pilot Projects; Rhabdomyosarcoma; Soft Tissue Neoplasms

2013

Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma.

Cancer, 2006, Feb-01, Volume: 106, Issue:3

Topics: Adolescent; Antineoplastic Agents, Phytogenic; Camptothecin; Child; Child, Preschool; Disease Progression; Drug Administration Schedule; Female; Humans; Infant; Infusions, Intravenous; Irinotecan; Male; Neutropenia; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome

2006

Other Studies

5 other study(ies) available for irinotecan and Soft Tissue Neoplasms

Article	Year
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine	2009
Treatment of childhood sarcoma with irinotecan: bilirubin level as a predictor of gastrointestinal toxicity. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:6 Topics: Adolescent; Antineoplastic Agents, Phytogenic; Bilirubin; Camptothecin; Child; Child, Preschool; Diarrhea; Female; Gastric Mucosa; Humans; Infant; Intestinal Mucosa; Irinotecan; Male; Predictive Value of Tests; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms	2009
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas. Journal of neurosurgery, 2007, Volume: 106, Issue:3 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Culture Techniques; Cell Line, Tumor; Disease Models, Animal; Irinotecan; Male; Meningioma; Mice; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Soft Tissue Neoplasms; Subcutaneous Tissue	2007
[Long- term remission survival with a case of rectal carcinoid tumor with metastasis in the soft tissue effectively treated with the combination therapy of irinotecan/5-fluorouracil/levofolinate followed by resection]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Nov-10, Volume: 96, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoid Tumor; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Middle Aged; Rectal Neoplasms; Rectum; Remission Induction; Soft Tissue Neoplasms; Time Factors; Treatment Outcome	2007
[Four cases of recurrent breast cancer effectively treated by the new antitumor agent, CPT-11 (irinotecan)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:8 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Camptothecin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Irinotecan; Lymphatic Metastasis; Mastectomy, Radical; Middle Aged; Soft Tissue Neoplasms	1994